Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.84 SEK -6.55%
Market Cap: 552.8m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Moberg Pharma AB (publ)
Income from Continuing Operations Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Income from Continuing Operations
-kr21.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Income from Continuing Operations
-kr480.4m
CAGR 3-Years
8%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Income from Continuing Operations
kr223.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Income from Continuing Operations
kr76.2m
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Income from Continuing Operations
-kr177.8m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Income from Continuing Operations
-kr190.4m
CAGR 3-Years
-40%
CAGR 5-Years
-21%
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Income from Continuing Operations?
Income from Continuing Operations
-21.1m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Income from Continuing Operations amounts to -21.1m SEK.

What is Moberg Pharma AB (publ)'s Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-34%

Over the last year, the Income from Continuing Operations growth was -34%.

Back to Top